SMMT: Summit Therapeutics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
Stocks in this Quantisnow insightHealth Care
Historical context for SMMT
Across the 21 sessions after earlier SMMT headlines, the stock closed higher 8 times and lower 13 times, with a median move of 2.2% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | SMMT | SPY |
|---|---|---|---|
| Jun 1, 2026 | Ivonescimab with Chemotherapy Demonstrated a Statistically Significant Overall Survival Benefit Compared to Tislelizumab Plus Chemotherapy in 1L Treatment of Patients with Squamous NSCLC in the HARMONi-6 Study Conducted by Akeso in Chinaand 1 other headline that session | -10.4% | +0.3% |
| May 22, 2026 | Summit Therapeutics downgraded by H.C. Wainwright | -4.9% | +0.4% |
| May 1, 2026 | Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2026 | -24.9% | +0.3% |
| Apr 8, 2026 | Stifel initiated coverage on Summit Therapeutics with a new price target | -2.1% | +2.5% |
| Mar 27, 2026 | Multiple Ivonescimab Data Sets from Phase III Studies in Advanced NSCLC Patient Populations to be Featured at ELCC 2026 | -3.9% | -1.7% |
| Mar 16, 2026 | Summit Therapeutics downgraded by Jefferies with a new price target | +0.3% | +1.0% |
Keep researching SMMT
- What is Form 8-K?The SEC "current report" a public company files to disclose material events, generally within four business days of the event.
- Form 8-K explainedWhat a Form 8-K is, when it is due, and what each key item number means, from 1.01 material agreements and 2.02 earnings to 4.02 restatements and 5.02 executive changes.
- SMMT insider tradesEvery buy and sale reported by Summit Therapeutics Inc. officers, directors and large holders.
- SMMT earnings historyPast Summit Therapeutics Inc. earnings releases, newest first.
- SMMT financial statementsRevenue, profit, cash flow and balance sheet from Summit Therapeutics Inc.'s SEC filings.
Quantisnow market dataNASDAQ
SMMT
Summit Therapeutics Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2015
Get push alerts for SMMT
Full SMMT profile on Quantisnow Follow SMMT and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time